Isotechnika psoriasis drug impresses in study
The Canadian late phase trial commenced on December 2, 2004 and includes a total of 453 patients with stable moderate to severe plaque psoriasis. The trial is currently
The Canadian late phase trial commenced on December 2, 2004 and includes a total of 453 patients with stable moderate to severe plaque psoriasis. The trial is currently
The clinical development of the drug, which has been granted orphan drug designation in the US and Europe, is about to enter a phase III clinical study in
Researchers looking for such a link have focused on acetaldehyde, a suspected carcinogen formed as the body metabolizes alcohol. The researchers claim that polyamines – natural compounds essential
AA4500 is being developed by Auxilium, whilst Cobra will continue to provide manufacturing services and supply the drug for phase II/III clinical trials. “We have been impressed with
The drugs in question are daclizumab in multiple sclerosis and indications other than transplant and respiratory diseases, M200 (volociximab), and HuZAF (fontolizumab) in all indications. Protein Design Labs
More than 120 sites across the US have been enlisted and most are now screening and enrolling patients into the study. Myriad anticipates completing enrollment for the 12-month
The grant is a fast-track phase I/II Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health. Currently, the
“The increasing number of less invasive procedures, particularly endoscopic and laprascopic procedures requires more demanding suture knot tying skills,” noted Wade Fallin, president and CEO of MedicineLodge. “These
Cooled ThermoTherapy uses targeted microwave energy combined with a unique cooling mechanism to provide safe, effective and lasting relief from benign prostatic hyperplasia (BPH) symptoms. BPH, also known
European legislation requires manufacturers to display CE Marking on their products, packaging and accompanying literature. The CE Marking on a product allows it to be legally placed on